Trial Profile
A Phase III study of M071754 - A single-blind study in patients with infantile spasms -
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Dec 2018
Price :
$35
*
At a glance
- Drugs Vigabatrin (Primary)
- Indications Infantile spasms
- Focus Therapeutic Use
- Sponsors Alfresa Pharma Corporation
- 06 Jun 2016 New trial record